Mar 5, 2024 9:15am EST MyMD Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing
Feb 13, 2024 11:45am EST MyMD Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing